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Background: TCF7L2 is a central transcription factor in the canonical wingless-type MMTV integration site (WNT)
signaling pathway, and genetic variants in TCF7L2 have been found to interact with dietary fiber intake on type 2
diabetes risk. Here, we investigate whether other type 2 diabetes genes could be involved in the WNT signaling
pathway and whether variants in such genes might interact with dietary fiber on type 2 diabetes incidence.
Results: We included 26,905 individuals without diabetes from the Malmö Diet and Cancer Study cohort. Diet data
was collected at baseline using a food frequency questionnaire, a 7-day food record, and an interview. Altogether,
51 gene loci were analyzed for putative links to WNT signaling. Over a mean follow-up period of 14.7 years, 3132
incident cases of type 2 diabetes were recorded. Seven genes (nine single nucleotide polymorphisms (SNPs)) were
annotated as involved in WNT signaling including TCF7L2 (rs7903146 and rs12255372), HHEX (rs1111875), HNF1A
(rs7957197), NOTCH2 (rs10923931), TLE4 (rs13292136), ZBED3 (rs4457053), and PPARG (rs1801282 and rs13081389).
SNPs in TCF7L2, NOTCH2, and ZBED3 showed significant interactions with fiber intake on type 2 diabetes incidence
(Pinteraction = 0.034, 0.005, 0.017, and 0.002, respectively). The magnitude of the association between the TCF7L2 risk
allele and incident type 2 diabetes increased from the lowest to the highest quintiles of fiber intake. Higher fiber
associated with lower type 2 diabetes risk only among risk allele carriers of the NOTCH2 variant and homozygotes
of the risk allele of the ZBED3 variant.
Conclusions: Our results suggest that several type 2 diabetes susceptibility SNPs in genes involved in WNT
signaling may interact with dietary fiber intake on type 2 diabetes incidence.
Keywords: Gene-diet interactions, TCF7L2, WNT signaling, Type 2 diabetes, Dietary fiberBackground
Type 2 diabetes is a multifactorial disease, and both
genetic and environmental factors, and their complex
interactions, are thought to contribute to the disease
development. Recently, more than 80 type 2 diabetes
associated genetic variants have been discovered
mainly through genome-wide association studies
(GWAS) [24, 28]. Of these, the transcription factor 7-
like 2 gene (TCF7L2) variant rs7903146 shows the
strongest association with type 2 diabetes [12].* Correspondence: george.hindy@med.lu.se
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nonical wingless-type MMTV integration site (WNT)
signaling pathway [29]. This highlights the importance
of the canonical WNT pathway in the pathogenesis of
type 2 diabetes. Many studies have demonstrated an es-
sential role for the WNT signaling pathway in pancre-
atic islet beta cell genesis and proliferation [33].
Glucagon-like peptide-1 (GLP-1)-mediated proliferation
of rat beta cell line (INS-1) has been shown to occur
through activation of the WNT pathway [19]. In
addition, WNT signaling has been reported to mediate
the expression of the pro-glucagon gene in intestinal L
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prevent pre-adipocyte differentiation [32].
Several studies have reported a protective association
between higher dietary fiber intake and type 2 diabetes
[25, 39]. This inverse relationship seems to be likely
driven by the cereal fiber component. In a meta-analysis
of prospective studies, cereal fiber but not vegetable/fruit
fiber intake has been shown to associate with lower risk
of type 2 diabetes [34]. Short chain fatty acids (SCFA),
the by-products of colonic fermentation of dietary fiber,
have been reported to hyper-activate WNT signaling in a
colorectal cell line [5]. Fiber intake could thus exert its
protective effect at least partially by modifying WNT
activity through SCFAs. SCFAs have previously been as-
sociated with increased insulin secretion [27], promotion
of adipocyte differentiation [44], and induction of GLP-1
secretion via the free fatty acid receptor 2 (FFAR2) [36].
Biological interactions could conceivably occur between
fiber intake through SFCAs and the WNT pathway on
type 2 diabetes risk at the level of pancreatic beta cells,
intestinal L cells, or adipocytes.
We have previously reported that the protective asso-
ciated effect of higher fiber intake may be restricted to
the non-risk CC genotype carriers of TCF7L2 rs7903146
[14]. Similar results were also reported in the EPIC-
Potsdam case-control study showing a protective associ-
ation between higher whole grain intake and type 2
diabetes only among the non-risk allele carriers [9]. In
line with these results, lower risk of type 2 diabetes by
higher whole grain and cereal fiber intake was restricted
to the non-risk allele carriers in a subgroup of men inTable 1 Association between fiber intake and type 2 diabetes and r
Quintiles of fiber intake
Total Q1 Q2 Q3
N 26,905 5381 5381 538
Sex (% males) 10,429 (39 %) 3039 (57 %) 2426 (45 %) 206
Age (years) 58.0 ± 7.6 57.4 ± 7.5 57.7 ± 7.7 58.
Incident type 2 diabetes 3132 (10.6 %) 666 (11.3 %) 650 (11.0 %) 670
BMI (kg/m2) 25.6 ± 3.9 25.5 ± 3.9 25.6 ± 3.8 25.
FPG (mmol/L)b 5.64 ± 0.82 5.81 ± 1.04 5.68 ± 0.78 5.6
FPI (pmol/L)b 46.5 ± 46.2 50.7 ± 43.5 46.2 ± 33.6 47.
HOMA-IRb 1.60 ± 1.22 1.75 ± 1.32 1.64 ± 1.06 1.6
HbA1C (%)
b 4.81 ± 0.49 4.89 ± 0.58 4.82 ± 0.45 4.8
HbA1C (mmol/mol)
b 39.7 ± 5.00 40.5 ± 5.88 39.8 ± 4.56 39.
Fiber (g/1000 Kcal) 9.03 ± 2.72 5.77 ± 0.81 7.47 ± 0.36 8.6
Data are means ± SD unless otherwise stated. Number of individuals included in MD
HR hazard ratio, BMI body mass index, FPG fasting plasma glucose, FPI fasting plasm
glycated hemoglobin
aAdjusted for age, sex, BMI, total energy intake, dietary assessment method, season
where appropriate
bData available only for the MDC-CC, n = 5499the Stockholm Diabetes Prevention Program [42]. Fur-
ther, another lifestyle intervention demonstrated a
greater weight loss by higher fiber intake after a 9-
month intervention among individuals carrying the non-
risk CC genotype compared to risk allele carriers [13].
As association between TCF7L2 and type 2 diabetes
has highlighted an important role for WNT signaling in
type 2 diabetes pathogenesis, we therefore used pathway
analysis tools to evaluate whether other type 2 diabetes
associated loci might be connected to this pathway. As
several studies have indicated that dietary fiber or whole
grain intake might modify the association between
TCF7L2 variants and type 2 diabetes or weight loss, we
hypothesized that additional type 2 diabetes susceptibil-
ity genes in the WNT pathway may interact with fiber
intake on type 2 diabetes incidence.Results
Association between fiber intake and type 2 diabetes
incidence and related quantitative traits
Association between fiber intake and type 2 diabetes in-
cidence and related quantitative traits in the Malmö Diet
and Cancer Study (MDCS) are shown in Table 1. A total
of 3132 incident cases of type 2 diabetes were recorded
after a mean follow-up time of 14.7 years. Higher fiber
intake was observed to strongly associate (P < 0.001)
with reduced baseline fasting plasma glucose (FPG), fast-
ing plasma insulin (FPI), homeostasis model for assess-
ment of insulin resistance (HOMA-IR), and glycated
hemoglobin (HbA1C) (Table 1).elated traits in MDCS
Q4 Q5 Βeta (SE) or HR (CI) P valuea
1 5381 5381
2 (38 %) 1635 (30 %) 1267 (24 %)
2 ± 7.7 58.3 ± 7.7 58.3 ± 7.5
(11.4 %) 564 (9.56 %) 582 (10.9 %) 0.98 (0.96–1.01) 0.17
8 ± 3.9 25.7 ± 3.9 25.5 ± 4.0 0.02 (0.02) 0.22
3 ± 0.79 5.58 ± 0.73 5.54 ± 0.72 −0.03 (0.008) 0.0001
5 ± 50.5 45.1 ± 59.3 43.9 ± 38.9 −0.95 (0.48) 6 × 10−07
5 ± 1.62 1.53 ± 1.04 1.48 ± 1.00 −0.06 (0.01) 6 × 10−09
2 ± 0.53 4.80 ± 0.43 4.76 ± 0.47 −0.02 (0.005) 0.00002
8 ± 5.36 39.5 ± 4.38 39.2 ± 4.75 −0.22 (0.05) 0.00002
9 ± 0.36 10.09 ± 0.48 13.13 ± 2.19
CS cohort, n = 26,905
a insulin, HOMA-IR homeostatic model assessment for insulin resistance, HbA1C
, leisure-time physical activity, smoking, alcohol intake, and education
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WNT pathway
A total of nine type 2 diabetes associated genes were an-
notated to the WNT signaling pathway, and of these,
seven genes (nine single nucleotide polymorphisms
(SNPs)) were annotated and selected for further analyses.
We included SNPs mapping to genes with roles upstream
of TCF7L2 in the WNT signaling pathway. Functional po-
sitioning of these genes within the WNT pathway is
detailed in the Additional file 1: Figure S1. These included
TCF7L2 (rs7903146 and rs12255372), HHEX (rs1111875),
HNF1A (rs7957197), NOTCH2 (rs10923931), TLE4 (rs132
92136), ZBED3 (rs4457053), and PPARG (rs1801282 and
rs13081389).
Association between WNT-annotated gene variants and
type 2 diabetes and related traits
Both TCF7L2 variants (rs7903146 and rs12255372),
HHEX rs1111875, and HNF1A rs7957197 were associ-
ated with increased risk of type 2 diabetes (Table 2). In
addition, the TCF7L2 variants and the HNF1A variant
associated with elevated baseline FPG. The HHEX vari-
ant associated with lower baseline FPI, and the TCF7L2
variants and the ZBED3 variant associated with elevated
baseline HbA1C (Table 2).
Interaction between WNT-annotated gene variants and
fiber intake on incidence of type 2 diabetes
The TCF7L2 rs7903146 variant interacted with quintiles
of fiber intake on type 2 diabetes incidence (Pinteraction =
0.034). Additionally, another TCF7L2 variant, rs12255372,
showed a somewhat stronger interaction with fiber intake
on type 2 diabetes incidence (Pinteraction = 0.005) (Table 3).
The magnitude of the associated effect of the TCF7L2 risk
allele on type 2 diabetes incidence was higher among indi-
viduals in the higher fiber intake quintiles as compared to
individuals in the lower quintiles. Moreover, individuals inTable 2 Association between SNPs in WNT-associated genes and ty
Incident type 2 diabetesa FPG (mmol/L)b
HR (95 % CI) P value Beta (SE)
TCF7L2 rs7903146 1.33 (1.25–1.40) 1 × 10−23 0.04 (0.02)
TCF7L2 rs12255372 1.24 (1.17–1.31) 9 × 10−14 0.03 (0.02)
HHEX rs1111875 1.06 (1.01–1.12) 0.03 −0.02 (0.02)
HNF1A rs7957197 1.12 (1.05–1.20) 0.001 0.04 (0.02)
NOTCH2 rs10923931 0.99 (0.91–1.09) 0.90 0.04 (0.03)
TLE4 rs13292136 1.03 (0.94–1.12) 0.60 −7 × 10−05 (0.03)
ZBED3 rs4457053 1.01 (0.96–1.08) 0.64 0.01 (0.02)
PPARG rs1801282 1.08 (1.00–1.16) 0.051 0.03 (0.02)
PPARG rs13081389 1.00 (0.91–1.11) 0.97 0.03 (0.03)
HR hazard ratio, FPG fasting plasma glucose, FPI fasting plasma insulin, HbA1C glyca
aAdjusted for age and sex, N = 26,905
bAdjusted for age and sex; data available only for the MDC-CC, N = 5499the lowest fiber quintile did not show any increased risk
of type 2 diabetes by the risk (T) allele of rs12255372
(Table 4). Higher fiber intake showed a tendency for asso-
ciation with lower risk of type 2 diabetes among non-risk
GG genotype carriers of rs12255372 (hazard ratio (HR)
0.96; 95 % confidence interval (CI) 0.92–1.00; P = 0.06)
but not among GTand TT genotype carriers.
Of the WNT-annotated SNPs (in genes upstream of
TCF7L2), we found, in addition to TCF7L2, the SNPs in
NOTCH2 and ZBED3 loci (Table 4) to significantly
interact with fiber intake on type 2 diabetes incidence.
The NOTCH2 locus was observed to interact with fiber
intake on type 2 diabetes incidence (Pinteraction = 0.017).
Higher fiber intake was observed to associate with lower
risk of type 2 diabetes only among carriers of the risk
(T) allele; GT (HR 0.93; CI 0.87–0.996; P = 0.038); and
TT (HR 0.63; CI 0.44–0.90; P = 0.01). The NOTCH2 risk
allele did not associate with type 2 diabetes incidence in
the whole population (HR 0.99; CI 0.91–1.09; P = 0.90);
however, it was associated significantly with decreased
risk of type 2 diabetes in the fourth fiber intake quintile
(HR 0.75; CI 0.60–0.95; P = 0.015) (Table 4). Another
interaction was observed between quintiles of fiber in-
take and ZBED3 rs4457053 on type 2 diabetes incidence
(Pinteraction = 0.002). Higher fiber intake was observed to
associate with lower risk of type 2 diabetes only among
homozygotes for the risk (G) allele (HR 0.85; CI 0.76–
0.95; P = 0.003) (Table 4).Discussion
In this prospective study, we observe interactions between
dietary fiber intake and variants in three genes annotated
to the canonical WNT signaling pathway influencing the
risk of type 2 diabetes in a large population-based cohort
over a 15-year follow-up period. This indicates a putative
role of the WNT pathway in the pathogenesis of type 2pe 2 diabetes and related traits in MDCS
FPI (pmol/L)b HbA1C (%)
b
P value Beta (SE) P value Beta (SE) P value
0.03 0.16 (1.05) 0.82 0.02 (0.01) 0.04
0.15 −0.73 (1.07) 0.79 0.02 (0.01) 0.07
0.20 −3.07 (0.99) 0.016 0.01 (0.01) 0.31
0.04 1.11 (1.23) 0.54 0.01 (0.01) 0.30
0.19 −0.14 (1.73) 0.69 0.02 (0.02) 0.35
1.00 1.71 (1.72) 0.40 0.02 (0.02) 0.30
0.44 −1.41 (1.14) 0.22 0.02 (0.01) 0.04
0.24 1.16 (1.38) 0.42 −0.002 (0.01) 0.88
0.35 1.67 (1.79) 0.33 0.01 (0.02) 0.68
ted hemoglobin
Table 3 Interaction between variants in WNT-associated genes and quintiles of fiber intake on type 2 diabetes incidence
Genotype HRb, c, d, e 95 % CI Pb, c, d, e
Alleles Risk allele XX XRa RR
TCF7L2 rs7903146 C/T T 13,475 9414 1720 1.20c 1.05–1.36 0.006
Fiber 0.96d 0.93–0.998 0.037
TCF7L2 rs7903146 × Fiber 1.04e 1.003–1.09 0.034
TCF7L2 rs12255372 G/T T 13,517 9689 1785 1.06 0.93–1.21 0.36
Fiber 0.95 0.91–0.98 0.003
TCF7L2 rs12255372 × Fiber 1.06 1.02–1.10 0.005
HHEX rs1111875 A/G G 4329 12,518 8816 0.99 0.88–1.11 0.83
Fiber 0.95 0.90–1.00 0.05
HHEX rs1111875 × Fiber 1.03 0.99–1.07 0.14
HNF1A rs7957197 A/T T 1067 8549 16,401 1.15 0.99–1.34 0.06
Fiber 1.00 0.92–1.08 0.92
HNF1A rs7957197 × Fiber 0.99 0.95–1.04 0.75
NOTCH2 rs10923931 G/T T 20,612 4372 228 1.24 1.02–1.51 0.035
Fiber 1.00 0.97–1.03 0.97
NOTCH2 rs10923931 × Fiber 0.93 0.87–0.99 0.017
TLE4 rs13292136 C/T C 186 3928 21,962 0.99 0.81–1.23 0.96
Fiber 0.97 0.86–1.10 0.66
TLE4 rs13292136 × Fiber 1.01 0.94–1.07 0.88
ZBED3 rs4457053 A/G G 13,455 9362 1642 1.22 1.06–1.39 0.004
Fiber 1.02 0.98–1.05 0.38
ZBED3 rs4457053 × Fiber 0.94 0.90–0.98 0.002
PPARG rs1801282 G/C C 548 6263 19,038 1.18 0.99–1.40 0.06
Fiber 1.01 0.92–1.12 0.77
PPARG rs1801282 × Fiber 0.98 0.93–1.04 0.52
PPARG rs13081389 A/G A 165 3256 21,423 0.97 0.77–1.21 0.77
Fiber 0.93 0.81–1.07 0.30
PPARG rs13081389 × Fiber 1.03 0.96–1.10 0.46
HR hazard ratio
aX designates the non-risk allele and R designates the risk allele
bAdjusted for age, sex, BMI, total energy intake, dietary assessment method, season, leisure-time physical activity, smoking, alcohol intake, and education
cMain effect per risk allele from the multivariable model including the interaction term
dMain effect per quintile of fiber intake from the multivariable model including the interaction term
eInteraction effect
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through this pathway.
Annotation of the 51 gene loci corresponding to 58 SNPs
associated with type 2 diabetes resulted in identification of
seven genes having known connections with WNT signal-
ing. We could replicate our previous finding of interaction
between TCF7L2 variants and fiber intake in relation to the
risk of developing type 2 diabetes over time [14]. In
addition, novel interactions between dietary fiber intake
and two type 2 diabetes-associated variants in the NOTCH2
and ZBED3 loci were observed. Higher fiber intake was ob-
served to associate with lower incidence of type 2 diabetes
only among risk allele carriers of the NOTCH2 variant and
homozygotes for the risk allele of the ZBED3 variant.The WNT pathway may play a central role in the
pathogenesis of type 2 diabetes. Pancreatic beta cell gen-
esis and GLP-1-mediated proliferation have been shown
to be mediated through activation of the WNT pathway
[19, 33]. In addition to effects on beta cells, the WNT
pathway mediates pro-glucagon gene expression in in-
testinal L cells and thus the synthesis of GLP-1 [43]. Ac-
tivation of the WNT pathway has been shown to keep
pre-adipocytes in their undifferentiated state and could
eventually result in ectopic fat accumulation and insulin
resistance [32]. Recently, a liver-specific knock out of
tcf7l2 in mice was linked to reduced hepatic glucose pro-
duction [4]. WNT transcriptional activity has been re-
ported to be hyper-activated by butyrate which is one of
Table 4 HR of incident type 2 diabetes by genotype and quintiles of fiber intake
Genotype




Q1 1.16 (0.98–1.39) 1.58 (1.32–1.89) 1.56 (1.14–2.15) 1.24 (1.09–1.40) 0.001 0.034
Q2 1.13 (0.95–1.35) 1.52 (1.27–1.82) 1.92 (1.43–2.60) 1.26 (1.11–1.42) 0.0002
Q3 1.15 (0.97–1.37) 1.62 (1.36–1.93) 2.10 (1.60–2.77) 1.37 (1.22–1.55) 1 × 10−7
Q4 1.02 (0.85–1.22) 1.35 (1.12–1.62) 1.93 (1.48–2.58) 1.31 (1.15–1.49) 5 × 10−5
Q5 1 (ref) 1.70 (1.42–2.03) 2.00 (1.49–2.70) 1.47 (1.30–1.66) 2 × 10−9
HR per Q 0.97 (0.93–1.01) 0.99 (0.95–1.03) 1.05 (0.95–1.15)
Ptrend
c 0.19 0.64 0.37
TCF7L2 rs12255372
Q1 1.22 (1.03–1.45) 1.44 (1.20–1.73) 1.27 (0.90–1.78) 1.08 (0.95–1.22) 0.26 0.005
Q2 1.16 (0.98–1.38) 1.32 (1.10–1.58) 1.74 (1.31–2.32) 1.16 (1.02–1.31) 0.02
Q3 1.07 (0.90–1.28) 1.53 (1.29–1.82) 1.89 (1.44–2.47) 1.36 (1.21–1.53) 3 × 10−7
Q4 1.02 (0.86–1.22) 1.27 (1.05–1.52) 1.68 (1.25–2.26) 1.23 (1.08–1.40) 0.002
Q5 1 (ref) 1.41 (1.18–1.68) 1.99 (1.48–2.67) 1.40 (1.23–1.59) 4 × 10−7
HR per Q 0.96 (0.92–1.00) 0.98 (0.94–1.02) 1.05 (0.96–1.16)
Ptrend 0.060 0.37 0.28
NOTCH2 rs10923931
Q1 1.00 (0.87–1.14) 1.14 (0.92–1.42) 1.66 (0.86–3.23) 1.12 (0.93–1.34) 0.24 0.017
Q2 1.00 (0.88–1.14) 1.04 (0.85–1.28) 0.76 (0.28–2.04) 1.06 (0.88–1.28) 0.51
Q3 1.03 (0.91–1.18) 1.10 (0.90–1.35) 1.05 (0.47–2.34) 1.08 (0.90–1.30) 0.41
Q4 0.97 (0.85–1.11) 0.70 (0.55–0.90) 0.75 (0.28–2.00) 0.75 (0.60–0.95) 0.015
Q5 1 (ref) 1.00 (0.80–1.25) 0.25 (0.04–1.80) 0.93 (0.75–1.15) 0.50
HR per Q 1.00 (0.97–1.03) 0.93 (0.87–0.996) 0.63 (0.44–0.90)
Ptrend 0.89 0.038 0.010
ZBED3 rs4457053
Q1 0.96 (0.81–1.13) 1.03 (0.86–1.23) 1.51 (1.14–2.01) 1.16 (1.02–1.31) 0.06 0.002
Q2 0.96 (0.81–1.12) 1.00 (0.84–1.20) 1.04 (0.74–1.46) 1.03 (0.90–1.17) 0.36
Q3 1.04 (0.89–1.21) 1.04 (0.88–1.24) 0.85 (0.59–1.22) 0.99 (0.87–1.12) 0.97
Q4 0.93 (0.79–1.09) 0.93 (0.78–1.12) 0.67 (0.46–0.99) 0.95 (0.83–1.10) 0.55
Q5 1 (ref) 0.98 (0.82–1.17) 0.72 (0.50–1.04) 0.94 (0.81–1.07) 0.25
HR per Q 1.01 (0.97–1.05) 0.98 (0.94–1.03) 0.85 (0.76–0.95)
Ptrend 0.69 0.40 0.003
HR hazard ratio, Q quintile
aX designates the non-risk allele and R designates the risk allele
bAdjusted for age and sex
cAdjusted for age, sex, BMI, total energy intake, dietary assessment method, season, leisure-time physical activity, smoking, alcohol intake, and education
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ary fiber leading to apoptosis of colorectal cancer cells
[5, 17]. Fiber intake is mainly linked to elevated luminal
concentrations of SCFAs in the intestines. In addition, it
has been linked to elevated SCFAs in plasma after 1 year
of high-fiber intervention [10]. Fiber intake could thus at
least partially exert its systemic anti-diabetogenic effects
through modulation of the WNT signaling pathway by
SCFAs.In line with our previous report, we observed an inter-
action between TCF7L2 rs7903146 and fiber intake on
type 2 diabetes incidence. However, our present study
included 3132 type 2 diabetes cases instead of 1649 cases
in our previous study [14]. Another TCF7L2 SNP
(rs12255372) showed a somewhat stronger interaction
with fiber. However, the two SNPs are in linkage dis-
equilibrium (r2 = 0.70 and D’ = 0.91) and are thus very
likely reflecting the same interaction. In this study, we
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in opposite direction with variants in NOTCH2 and
ZBED3 as compared to the TCF7L2 variants. Reports
from colon cancer research show that the WNT path-
way should not be viewed as having an additive effect
but rather as a continuum since both high and low
WNT activity has been shown to promote colorectal
cancer cell apoptosis [5, 17]. The dual role played by
TCF7L2 adds to this complexity where it can act as a
transcriptional activator in the presence of beta catenin
or as a repressor in the absence of beta catenin [3, 31].
This highlights the complexity by which WNT signaling
may operate in the pathogenesis of type 2 diabetes and
could explain the directional discrepancies observed in
the interactions with fiber. Both NOTCH2 and ZBED3
variants showed no association with type 2 diabetes risk
in MDCS with HRs close to null. Although this could be
partly because of power limitations due to the smaller
sample size compared to large-scale GWASs, the results
of our interaction analyses may indicate that environ-
mental factors such as higher fiber intake may in fact at-
tenuate and possibly reverse the risk associated with
these genetic variants.
The TCF7L2 rs7903146 shows the strongest associ-
ation with type 2 diabetes, as compared to more than 65
other loci identified to date among Europeans, with each
risk allele of rs7903146 associating with around 40 %
elevated risk of type 2 diabetes [28]. Most of the studies
so far have reported beta cell dysfunction and an attenu-
ated incretin effect associated with the risk allele [21,37].
A 1-year high-fiber intervention was linked to elevated
plasma SCFAs and GLP-1 in hyperinsulinemic subjects
[10]. Furthermore, SCFAs have been shown to induce
GLP-1 secretion via the FFAR2 in mice [36]. Therefore,
the carriers of the TCF7L2 risk allele may suffer from
beta cell incretin resistance and thus could be less prone
to the beneficial associated effects of higher fiber intake
through increased GLP-1 secretion. SCFAs, and particu-
larly butyrate, are potent histone deacetylase inhibitors
(HDACi), and this is particularly important as the
TCF7L2 variant has been linked to an islet-specific open
chromatin state which could be exacerbated by higher
fiber intake [11]. ZBED3 has been recently identified as
an axin-binding protein that modulates the WNT signal-
ing pathway [8]. Binding of the ZBED3 to axin prevents
the formation of the destruction complex that normally
phosphorylates beta catenin and targets it for proteasomal
degradation. ZBED3 risk allele has been shown to be asso-
ciated with increased ZBED3 expression in adipose tissue,
and this could translate to elevated WNT activity [38].
The NOTCH2 gene encodes a transmembrane protein
which physically associates with active beta catenin and
decreases its levels leading to lower WNT activity in bothstem and colon cancer cells [16]. However, whether the
NOTCH2 variant associates with NOTCH2 expression is
not yet known.
The high relative validity of our dietary assessment
method, the combination of a diet diary with a question-
naire, the large sample size, and the prospective design
with a long follow-up period are the major strengths of
our study. In addition, the detailed and extensive ascer-
tainment of type 2 diabetes cases from more than six
registers is another strength that decreases error and im-
proves the power of our study. However, our study has
several limitations that need to be discussed. First of all,
the T2D gene loci used for annotation were obtained
from the GWASs which in most cases are based on
proximity to the SNPs and are not necessarily the causal
genes. Further, although our study population is large, it
still has a limited power for detecting interactions which
could result in many false negative outcomes. Therefore,
replication of our results in other studies with reason-
able power and good quality of diet data is important.
We did not correct for multiple testing as our study is
hypothesis driven, and we believe that the selected
WNT-associated genes are biologically dependent and
the interactions with the NOTCH2 and ZBED3 variants
may reflect essentially the interactions with TCF7L2. Fi-
nally, our diet data was collected at baseline and may fail
to detect the effect of the changes in dietary habits over
the follow-up period.
Conclusions
Our results indicate that several type 2 diabetes suscepti-
bility SNPs in genes involved in WNT signaling may
interact with dietary fiber intake on type 2 diabetes inci-
dence. The putative mechanisms by which fiber intake
could modify WNT signaling through these variants in
type 2 diabetes pathogenesis include effects on beta cell
survival, adipogenesis and adipocyte proliferation, and/
or GLP-1 production in intestinal L cells. In addition,
functional studies are needed to better understand the
putative role played by dietary fiber in type 2 diabetes
through the WNT signaling pathway.
Methods
Study population
The MDCS is a population-based prospective cohort in
the city of Malmö in Sweden. The source population
(74,138 individuals) was defined in 1991 to include all
individuals living in Malmö and born between the years
1926 and 1945. In 1995, this definition was modified to
include all men born between 1923 and 1945 and
women born between 1923 and 1950 [2, 22]. Study par-
ticipants were recruited through public advertisements
or personal letters. Individuals with mental disability and
limited Swedish language skills were excluded. Study
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baseline examination period between March 1991 and
October 1996. During the first visit, participants received
instructions on recording their meals in the menu book
and on filling in the diet questionnaire and the extensive
questionnaire covering socioeconomic and lifestyle fac-
tors. Approximately 10 days later, subjects returned for a
diet history interview. By the end of the baseline exam-
ination period, complete dietary, anthropometric and
lifestyle data, was collected for 28,098 participants. De-
tails of the recruitment procedures are described else-
where [23].
After exclusion of prevalent type 2 diabetes patients,
identified as individuals with a self-reported diabetes
diagnosis or on a self-reported anti-diabetic regimen, we
were left with 26,905 individuals for our prospective ana-
lyses. From the MDCS, 6103 individuals were randomly
selected to participate in a cardiovascular sub-cohort
(Malmö Diet and Cancer Study Cardiovascular Cohort
(MDC-CC)). Additional measurements were obtained
for these individuals, including analysis of FPG, FPI, and
HbA1C levels. After excluding prevalent cases of diabetes
and individuals with no diet data, this sub-cohort con-
sisted of 5499 individuals.
The MDCS was approved by the Ethical Committee at
Lund University (LU 51-90). All participants provided
written informed consent.Incident type 2 diabetes
Incident cases of type 2 diabetes were identified using
the nationwide Swedish National Diabetes Register [7],
the regional Diabetes 2000 register of the Scania region
[18], or the Swedish National Patient Register, which is
a principal source of data for numerous research
projects and which covers more than 99 % of all som-
atic and psychiatric hospital discharges and Swedish
hospital-based outpatient care [20]. Individuals could
also be classified as diabetes cases if their cause of
death was registered as diabetes in the Swedish Cause-
of-Death Register, which comprises all deaths in
Swedish residents occurring in Sweden or abroad [15],
if they had been prescribed anti-diabetic medication ac-
cording to the Swedish Prescribed Drug Register [40],
or if they had at least two HbA1C recordings ≥6.0 %
using the Swedish Mono-S standardization system (cor-
responding to 7.0 % according to the US National
Glycohemoglobin Standardization Program (NGSP)
and 52 mmol/mol using International Federation of
Clinical Chemistry and Laboratory Medicine units) in
the Malmö HbA1C register, which analyzed and cata-
loged all HbA1C samples at the Department of Clinical
Chemistry taken in institutional and non-institutional
care in the greater Malmö area from 1988 onwards.In addition, diabetes cases at the baseline examin-
ation of MDC-CC were identified based on self-
reports of a physician diagnosis or the use of diabetes
medication in a baseline questionnaire, or fasting
whole blood glucose of ≥6.1 mmol/L (corresponding
to FPG concentration of ≥7.0 mmol/L). Furthermore,
a diabetes diagnosis could be determined at the MDC-
CC reinvestigation between the years 2007 and 2012
based on self-reports of a physician diagnosis or the
use of diabetes medication based on a questionnaire
or FPG of ≥7.0 mmol/L or a 120-min value post-
OGTT plasma glucose of >11.0 mmol/L. A total of
3132 incident cases of type 2 diabetes were identified
during the mean follow-up period of 14.7 years until
December 2010.
Dietary assessment
A modified dietary history method specifically designed
for the MDCS was used consisting of a 7-day menu
book, a dietary 168-item questionnaire, and an interview.
In the menu book, participants were asked to record
lunch and dinner meals, cold beverages including alco-
hol, medicinal drugs, natural remedies, and nutrient
supplements. The 168-item questionnaire was used to
assess meal patterns, consumption frequencies, and por-
tion sizes of regularly consumed foods. A 48-page book-
let was used to help participants at home estimate the
portion sizes for the questionnaire. During the interview,
a more extensive book with photographs was used to
estimate portion sizes and dishes in the menu book. Par-
ticipants were also asked about their meal pattern, cook-
ing methods, and food choices.
The average daily intake of foods was calculated using
data from the menu book and diet questionnaire. The
MDC Food and Nutrient Database, which was derived
from PC KOST2-93 of the Swedish National Food Ad-
ministration, was used to convert the average daily food
intake to energy and nutrient intakes [6, 41].
A slight alteration of the coding routines for dietary
data was introduced in September 1994 [41]. A method
variable, classifying data collected before and after
September 1994, along with a four-category season vari-
able (i.e., winter, spring, summer, and autumn) was cre-
ated and used as covariate to adjust for variation in data
collection over time.
Dietary variables used in our analysis included total
energy intake and dietary fiber. Fiber intake was adjusted
for total energy intake by expressing it as grams per
1000 kcal. The relative validity of the dietary assessment
method in MDCS has previously been evaluated in a
sample of 50- to 69-year-old Malmö residents, 105
women, and 101 men. The reference method used was
18 days’ weighed food records (3 days every second
month) collected over 1 year. Energy-adjusted Pearson
Hindy et al. Genes & Nutrition  (2016) 11:6 Page 8 of 9correlation coefficients for fiber intake was 0.69 for
women and 0.74 for men [30].
Other variables used as potential confounders
An extensive lifestyle questionnaire adapted from the
Minnesota Leisure Time Physical Activity Questionnaire
was used to assess leisure-time physical activity. Partici-
pants had to estimate the number of minutes per week
for each season they spent performing each of 17 differ-
ent physical activities. The duration was multiplied by
an intensity factor to create a physical activity score that
was divided into tertiles. Alcohol intake was classified
into four categories based on grams of alcohol con-
sumed per day: zero-consumers, low (<15 g/day in
women or <20 g/day in men), medium (15–30 g/day in
women or 20–40 g/day in men), and high consumers
(>30 g/day in women or >40 g/day in men). Participants
were classified as current smokers, ex-smokers, and
never-smokers. The education variable was created by
classifying participants according to their highest educa-
tional level (≤8 years, 9–10 years, and 11–13 years at
school and university degree).
Genotyping
A total of 58 previously reported type 2 diabetes-
associated single nucleotide polymorphisms were se-
lected for genotyping in the MDCS (Additional file 1:
Table S1) [24, 28]. Genotyping was performed by Mas-
sARRAY iPLEX (Sequenom, San Diego, CA, USA) or
Taqman 5′ nuclease (Applied Biosystems, Foster City,
CA, USA) assays according to the manufacturers’ in-
structions. The concordance rate was >99 % in 5500
samples which were genotyped using Human Omni
Express Exome Bead Chip Kit (Illumina, San Diego,
CA, USA). Genotyping success rate ranged between
96 and 99 %. All genotypes were in the Hardy-
Weinberg equilibrium (P > 0.0009).
Gene annotation
A list of 51 unique gene loci, corresponding to 58 SNPs
(MDCS) associated with type 2 diabetes, were analyzed for
links to WNT signaling (Additional file 1: Table S2) using a
combination of annotation from the Gene Ontology [1],
the Kyoto Encyclopedia of Genes and Genomes (http://
www.kegg.jp/kegg/, accessed on the 15th of March 2013),
Biocarta pathways (http://cgap.nci.nih.gov/Pathways/BioCarta_
Pathways, accessed on the 15th of March 2013), Panther
pathways [26, 35], and Literature integrated within the
DAVID Annotation Bioinformatics Resource (http://david.
abcc.ncifcrf.gov, accessed on the 15th of March 2013).
Statistical analysis
Assuming an additive model, Cox proportional hazards
regression was used to calculate the HR of incident type2 diabetes associated with each risk allele in the MDCS
adjusting for age and sex. After stratification to quintiles
of relative intakes of fiber (g/1000 kcal), interactions
between the SNP genotypes and quintiles of fiber in-
takes on type 2 diabetes incidence were analyzed by
introducing a multiplicative factor of the genotype and
dietary quintiles as continuous variables in addition to
these variables to the equation. Interactions were ana-
lyzed adjusting for age, sex, BMI, total energy intake,
dietary assessment method, season leisure-time phys-
ical activity, alcohol intake, smoking habits, and level
of education. In the MDC-CC sub-cohort, we per-
formed cross-sectional analysis using linear regression
to calculate the effect sizes of each WNT-annotated
risk allele on baseline FPG, FPI, HOMA-IR, and
HbA1C adjusting for age and sex.
We used IBM SPSS Statistics, version 19 (IBM Cor-
poration, Armonk, NY, USA), for the analyses. Two-
sided P values of <0.05 were considered significant.
Compliance with ethics guidelines
All procedures followed were in accordance with the
ethical standards of the responsible committee on hu-
man experimentation (Ethical Committee at Lund Uni-
versity LU 51-90) and with the Helsinki Declaration of
1975, as revised in 2000. Informed consent was obtained
from all participants for being included in the study.
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